The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EMMA Vienna 2017 | How are viral and bacterial infections managed in myeloma patients?
Heinz Ludwig, MD, of the Wilhelminen Cancer Research Institute, Vienna, Austria discusses the type of prophylaxis needed for the prevention and management of both viral and bacterial infections in myeloma. He stresses the importance of influenza vaccinations and of managing bacterial infections with antibiotic prophylaxis, including fluoroquinolone, Bactrim and amoxicillin in high-risk patients. Prof. Ludwig highlights that once the patient is in remission, administration of antibiotics must stop.
Recorded at the 2017 European Multiple Myeloma Academy (EMMA) in Vienna, Austria.
This program was sponsored by Celgene through an unrestricted educational grant to Video Journal of Hematological Oncology.
